<DOC>
	<DOCNO>NCT02470507</DOCNO>
	<brief_summary>The immune response kidney damage acute kidney injury ( AKI ) important contributor prolong lack renal function progression kidney injury . Most data related intrarenal interorgan pathway AKI stem animal research sometimes conflict result . Accurate evaluation process human identification early diagnostic tool critical development strategy prevent attenuate AKI-related morbidity mortality patient . The aim study evaluate immune function miRNA expression hospitalise patient without AKI .</brief_summary>
	<brief_title>Immune Function Acute Kidney Injury</brief_title>
	<detailed_description>Hypothesis : An override pro-inflammatory immune response underlies AKI human contribute dysfunction non-renal organ Principal research question : Is AKI human associate predominantly pro-inflammatory immune response ? Secondary research question : 1 . Does AKI affect phenotypic characterisation function neutrophil ? 2 . Does severity AKI lead difference phenotypic characterisation function neutrophil ? 3 . What differences cytokine profile AKI patient without systemic inflammation ? 4 . What differences cytokine profile AKI patient systemic inflammation patient systemic inflammation without AKI ? 5 . Is correlation microRNA level patient AKI degree AKI , renal recovery patient outcome ? Study design : Observational non-interventional study Study population : 30 patient AKI stage II III * systemic inflammation without sepsis 30 patient AKI stage II III * systemic inflammation 30 patient systemic inflammation normal renal function 30 patient major surgery infection , SIRS AKI * AKI define KDIGO criterion Primary outcome Detection measurable phenotypic characteristic function leukocytes specific patient AKI . Secondary outcome : 1 . Differences phenotypic characterisation function neutrophil patient AKI stage II III . 2 . Differences phenotypic characterisation function neutrophil patient without AKI . 3 . Differences cytokine profile patient AKI systemic inflammation patient AKI without systemic inflammation 4 . Differences cytokine profile AKI patient systemic inflammation patient systemic inflammation without AKI 5 . Correlation microRNA level patient AKI renal recovery 6 . Correlation microRNA level patient AKI patient outcome 7 . Differences cytokine profile AKI patient without systemic inflammation patient without AKI without systemic inflammation / infection . Statistical analysis : For analysis laboratory variable describe immunological phenotype , standard statistical method apply . 1 ) When normal distribution assumption meet , group compare use ANOVA correspond contrast group group comparison ; 2 ) In absence normality ordinal variable , Kruskal Wallis apply multi-group comparison , Wilcoxon two-groups analysis . We apply multiple test correction via Benjamini-Hochberg FDR control . For analysis miRNA array data , first follow protocol quality control measure appropriate platform choice , subsequently carry statistical analysis use SAMr LIMMA package Bioconductor , via R software . Similarly , analysis PCR data , package HTqPCR bioconductor use quality control . Depending distribution final data , either non-parametric statistic , moderate t-test applied statistical comparison , correspond multiple test correction .</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Adult patient ( â‰¥ 18 year ) admit hospital ( incl ICU ) one following : 1. postoperative AKI II III systemic inflammation without sepsis 2. systemic inflammation normal renal function 3 . AKI II III without systemic inflammation 4. postsurgery normal renal function without SIRS infection Renal transplant patient Patients immunosuppressive drug ( except steroid ) Patients haematological malignancy Jehovah 's witness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>